{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:30:02Z","timestamp":1725582602426},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Lokalisierte Lymph\u00f6deme der Genitalregion sind insgesamt seltene Erkrankungen. Liegt ihnen eine angeborene Fehlentwicklung des Lymphgef\u00e4\u00dfsystems zugrunde, werden sie als prim\u00e4re Lymph\u00f6deme bezeichnet. Sekund\u00e4re Lymph\u00f6deme entstehen durch exogene Sch\u00e4digung von Lymphgef\u00e4\u00dfen infolge von z.\u202fB. operativen Eingriffen, \u00dcbergewicht, Filariasis, Radiotherapie oder tumor\u00f6sen Prozessen. Wir pr\u00e4sentieren den Fall eines Patienten mit lokalisiertem Lymph\u00f6dem der Genitalregion, f\u00fcr das sich ein bisher nicht diagnostiziertes Urothelkarzinom als urs\u00e4chlich erwies.<\/jats:p>","DOI":"10.1007\/s00105-024-05358-z","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T15:01:51Z","timestamp":1715180511000},"page":"729-732","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasmazytoides Urothelkarzinom: eine seltene Ursache des lokalisierten Lymph\u00f6dems","Plasmacytoid urothelial carcinoma: a rare cause of localized lymphedema"],"prefix":"10.1007","volume":"75","author":[{"given":"Sven-Niklas","family":"Burmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena-Lioba","family":"Michalowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Oellig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Matull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"5358_CR1","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-22-2158","volume":"28","author":"G Basile","year":"2022","unstructured":"Basile\u00a0G, Bandini\u00a0M, Gibb\u00a0EA et\u00a0al (2022) Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3\u2011Year Median Follow-Up Update of PURE-01 Trial. Clin Cancer Res 28:5107\u20135114","journal-title":"Clin Cancer Res"},{"key":"5358_CR2","doi-asserted-by":"crossref","unstructured":"Figueiredo AA, Lucon AM, Srougi M (2017) Urogenital Tuberculosis. Microbiol Spectr 5:120\u2013124","DOI":"10.1128\/microbiolspec.TNMI7-0015-2016"},{"key":"5358_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.prs.0000297635.33874.a5","volume":"121","author":"ES Garfein","year":"2008","unstructured":"Garfein\u00a0ES, Borud\u00a0LJ, Warren\u00a0AG et\u00a0al (2008) Learning from a\u00a0lymphedema clinic: an algorithm for the management of localized swelling. Plast Reconstr Surg 121:521\u2013528","journal-title":"Plast Reconstr Surg"},{"key":"5358_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey\u00a0PA, Moch\u00a0H, Cubilla\u00a0AL et\u00a0al (2016) The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B:\u00a0Prostate and Bladder Tumours. Eur Urol 70:106\u2013119","journal-title":"Eur Urol"},{"key":"5358_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/01.SMJ.0000053676.73249.E5","volume":"96","author":"RA Krathen","year":"2003","unstructured":"Krathen\u00a0RA, Orengo\u00a0IF, Rosen\u00a0T (2003) Cutaneous metastasis: a\u00a0meta-analysis of data. South Med\u00a0J 96:164\u2013167","journal-title":"South Med J"},{"key":"5358_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0560.2008.00990.x","volume":"36","author":"S Lu","year":"2009","unstructured":"Lu\u00a0S, Tran\u00a0TA, Jones\u00a0DM et\u00a0al (2009) Localized lymphedema (elephantiasis): a\u00a0case series and review of the literature. J\u00a0Cutan Pathol 36:1\u201320","journal-title":"J Cutan Pathol"},{"key":"5358_CR7","series-title":"Urologie","first-page":"1351","volume-title":"Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in","author":"CH Ohlmann","year":"2022","unstructured":"Ohlmann\u00a0CH, Kerkmann\u00a0M, Holtmann\u00a0L et\u00a0al (2022) Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in. Urologie, Bd. 61. An initiative of the Working Groups Urological Oncology (AUO) and Internal Oncology (AIO) in the German Cancer Society (DKG), Germany, S\u00a01351\u20131364"},{"key":"5358_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jaad.2014.01.907","volume":"71","author":"JA Plaza","year":"2014","unstructured":"Plaza\u00a0JA, Requena\u00a0L, Kazakov\u00a0DV et\u00a0al (2014) Verrucous localized lymphedema of genital areas: clinicopathologic report of 18\u00a0cases of this rare entity. J\u00a0Am Acad Dermatol 71:320\u2013326","journal-title":"J Am Acad Dermatol"},{"key":"5358_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10354-006-0296-3","volume":"156","author":"B Soucek-Hadwiger","year":"2006","unstructured":"Soucek-Hadwiger\u00a0B, Doller\u00a0W (2006) Secondary malignant lymphedema. Wien Med Wochenschr 156:309\u2013313","journal-title":"Wien Med Wochenschr"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-024-05358-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:06:16Z","timestamp":1725519976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-024-05358-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5358"],"URL":"https:\/\/doi.org\/10.1007\/s00105-024-05358-z","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"13 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.-N.\u00a0Burmann, A.-L.\u00a0Michalowitz, F.\u00a0Oellig, A.\u00a0Kreuter und J.\u00a0Matull geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}